COM(2023)193 EU - Regulation
Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency

Please note

This page contains a limited version of this dossier in the Parlementaire Monitor.

Contents

  1. Key information
  2. Key dates
  3. Related information
  4. Full version
  5. EU Monitor

1.

Key information

official title

Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006
 
Legal instrument Regulation
Decision making procedure ordinary legislative procedure (COD)
reference by COM-number i COM(2023)193 EN
Additional COM-numbers SWD(2023)194
procedure number i 2023/0131(COD)
CELEX number i 52023PC0193

2.

Key dates

Document 26-04-2023
Online publication 26-04-2023

3.

Related information

 

4.

Full version

This page is also available in a full version containing the latest state of affairs, the summary of the European Parliament Legislative Observatory, the legal context, other dossiers related to the dossier at hand, the stakeholders involved (e.g. European Commission directorates-general, European Parliament committees, Council configurations and even individual EU Commissioners and Members of the European Parliament), consultations relevant to the dossier at hand and finally documents of the European Parliament, the Council of Ministers and the European Commission.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

5.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.